Clinical Trial Update: Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the safety and tolerability of adjunctive clobazam in pediatric patients with Dravet syndrome. The study was terminated with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• CLOBAZAM (CLOBAZAM)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Dravet Syndrome | Phase 3 | Status: TERMINATED | Results posted: 2017-02-15